Collinge J - Search Results

1

mGlu5 receptors and cellular prion protein mediate amyloid-β-facilitated synaptic long-term depression in vivo.

Hu NW, Nicoll AJ, Zhang D, Mably AJ, O'Malley T, Purro SA, Terry C, Collinge J, Walsh DM, Rowan MJ. Hu NW, et al. Among authors: collinge j. Nat Commun. 2014 Mar 4;5:3374. doi: 10.1038/ncomms4374. Nat Commun. 2014. PMID: 24594908 Free PMC article.

2

Prion protein is necessary for normal synaptic function.

Collinge J, Whittington MA, Sidle KC, Smith CJ, Palmer MS, Clarke AR, Jefferys JG. Collinge J, et al. Nature. 1994 Jul 28;370(6487):295-7. doi: 10.1038/370295a0. Nature. 1994. PMID: 8035877

3

Rational targeting for prion therapeutics.

Mallucci G, Collinge J. Mallucci G, et al. Among authors: collinge j. Nat Rev Neurosci. 2005 Jan;6(1):23-34. doi: 10.1038/nrn1584. Nat Rev Neurosci. 2005. PMID: 15611724 Review.

4

Codon 129 polymorphism of the human prion protein influences the kinetics of amyloid formation.

Lewis PA, Tattum MH, Jones S, Bhelt D, Batchelor M, Clarke AR, Collinge J, Jackson GS. Lewis PA, et al. Among authors: collinge j. J Gen Virol. 2006 Aug;87(Pt 8):2443-2449. doi: 10.1099/vir.0.81630-0. J Gen Virol. 2006. PMID: 16847141

5

Targeting cellular prion protein reverses early cognitive deficits and neurophysiological dysfunction in prion-infected mice.

Mallucci GR, White MD, Farmer M, Dickinson A, Khatun H, Powell AD, Brandner S, Jefferys JG, Collinge J. Mallucci GR, et al. Among authors: collinge j. Neuron. 2007 Feb 1;53(3):325-35. doi: 10.1016/j.neuron.2007.01.005. Neuron. 2007. PMID: 17270731 Free article.

6

Preventing prion pathogenicity by targeting the cellular prion protein.

Nicoll AJ, Collinge J. Nicoll AJ, et al. Among authors: collinge j. Infect Disord Drug Targets. 2009 Feb;9(1):48-57. doi: 10.2174/1871526510909010048. Infect Disord Drug Targets. 2009. PMID: 19200015 Review.

7

Tau, prions and Aβ: the triad of neurodegeneration.

Reiniger L, Lukic A, Linehan J, Rudge P, Collinge J, Mead S, Brandner S. Reiniger L, et al. Among authors: collinge j. Acta Neuropathol. 2011 Jan;121(1):5-20. doi: 10.1007/s00401-010-0691-0. Epub 2010 May 16. Acta Neuropathol. 2011. PMID: 20473510 Free PMC article. Review.

8

Pharmacological chaperone for the structured domain of human prion protein.

Nicoll AJ, Trevitt CR, Tattum MH, Risse E, Quarterman E, Ibarra AA, Wright C, Jackson GS, Sessions RB, Farrow M, Waltho JP, Clarke AR, Collinge J. Nicoll AJ, et al. Among authors: collinge j. Proc Natl Acad Sci U S A. 2010 Oct 12;107(41):17610-5. doi: 10.1073/pnas.1009062107. Epub 2010 Sep 27. Proc Natl Acad Sci U S A. 2010. PMID: 20876144 Free PMC article.

9

Amyloid beta-protein dimers rapidly form stable synaptotoxic protofibrils.

O'Nuallain B, Freir DB, Nicoll AJ, Risse E, Ferguson N, Herron CE, Collinge J, Walsh DM. O'Nuallain B, et al. Among authors: collinge j. J Neurosci. 2010 Oct 27;30(43):14411-9. doi: 10.1523/JNEUROSCI.3537-10.2010. J Neurosci. 2010. PMID: 20980598 Free PMC article.

10

Prion propagation and toxicity in vivo occur in two distinct mechanistic phases.

Sandberg MK, Al-Doujaily H, Sharps B, Clarke AR, Collinge J. Sandberg MK, et al. Among authors: collinge j. Nature. 2011 Feb 24;470(7335):540-2. doi: 10.1038/nature09768. Nature. 2011. PMID: 21350487

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

512 results

Search Page